Saturday 17 October 2026 Export SKIN’s income statement to Excel — free account

SkinHealth Systems Inc.

SKIN Consumer Defensive Household & Personal Products

SkinHealth Systems Inc.’s revenue for fiscal 2025 (year ended December 2025) was $300.8 million, down 10.0% from fiscal 2024. In the quarter to June 2026, revenue fell 7.77%, EPS fell 112.5%, free cash flow fell 81.9% and total debt fell 4.93%, each against the same quarter a year earlier.

10.56 2.04 −16.19%

Follow SKIN

Alert me

Market cap: $82.0M
P/E: 0.0×
Fwd P/E: −3.3×
Dividend yield: —
F-score: 6/9
Altman Z: −0.45
Beneish M: −3.05
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 96.93%

Capital & Financial Ratios $m

Market Cap 81.98

Revenue 290.05

Net Income (28.43)

Free Cash Flow 16.64

Net Debt 139.14

Current Ratio 1.76

Debt/Equity 6.21

P/E ratio 0.00

Fwd P/E (3.25)

P/S ratio 4.72

P/B ratio 24.63

Past 5Y EPS Growth —

This Y EPS Growth (98.05%)

Next Y EPS Growth 75.81%

Next Y revenue growth (5.22%)

Next 5Y EPS Growth 34.97%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 71.30%

10-year low 10-year high

P/B against its own 10 years 88.69%

10-year low 10-year high

EV/Sales against its own 10 years 75.21%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2022	Powerpack
2021	Powerpack
2020	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	523	370	233	206
Receivables	55	28	23	20
Inventory	91	69	48	47
Other	—	—	—	—
	698	477	310	295

	2023	2024	2025	Q'26
Payables	45	22	16	16
ST’ Debt	—	—	124	103
Other	21	—	—	—
	115	68	186	168

Compound Annual Growth %

	10y	5y	3y
Sales	—	20.36%	(6.32%)
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	0.00%	(28.50%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	65	72	—	—	—
’25	70	78	71	82	301
’24	81	91	79	83	334
’23	86	117	97	97	398
’22	75	104	89	98	366
’21	48	67	68	78	260
’20	—	14	35	—	119

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(6)	3	—	—	—
’25	3	10	10	15	37
’24	(17)	6	10	16	16
’23	(13)	22	18	(5)	22
’22	(38)	(31)	(31)	(5)	(107)
’21	1	(33)	0	3	(28)
’20	—	(12)	0	(1)	(12)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(7)	1	—	—	—
’25	2	8	9	14	32
’24	(19)	4	8	16	9
’23	(35)	19	14	(7)	(10)
’22	(42)	(36)	(39)	(8)	(125)
’21	0	(37)	(2)	(5)	(44)
’20	—	(13)	(2)	(1)	(16)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.05)	(0.02)	—	—	—
’25	(0.08)	0.14	(0.09)	(0.06)	(0.07)
’24	0.00	0.00	(0.15)	(0.08)	(0.23)
’23	(0.17)	0.03	(0.56)	(0.07)	(0.76)
’22	0.21	0.04	0.00	0.05	0.30
’21	(0.09)	(1.52)	(1.63)	(0.12)	(3.67)
’20	—	(0.30)	(0.06)	(0.02)	(0.85)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	10.01	9.71	8.25	1.35	0.91	0.78	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	12.84	30.17	24.77	13.90	5.17	2.69
People
People	Employees	—	—	—	—	2	704	1,034	881	769	613
	Revenue/emp, $m	—	—	—	0.00	59.55	0.37	0.35	0.45	0.43	0.49
Income, $m
Income, $m	Revenue	—	—	—	167	119	260	366	398	334	301
	Gross margin, %	—	—	—	63.92	56.43	68.65	68.00	38.97	54.53	65.28
	EBT	—	—	—	(3)	(38)	(381)	45	(102)	(30)	(6)
	EBT margin, %	—	—	—	(1.76)	(32.31)	(146.35)	12.39	(25.60)	(8.84)	(1.97)
	Net income	—	0	—	(2)	(29)	(379)	44	(100)	(29)	(10)
	Depreciation	—	—	—	15	16	22	27	39	37	29
Per share, $
Per share, $	Revenue	—	—	—	5.18	3.47	2.55	2.48	3.02	2.70	2.38
	Earnings	—	—	—	(0.05)	(0.85)	(3.67)	0.30	(0.76)	(0.23)	(0.08)
	Cash flow	—	—	—	0.05	(0.36)	(0.28)	(0.72)	0.17	0.13	0.30
	Capex	—	—	—	(0.32)	(0.11)	(0.15)	(0.13)	(0.24)	(0.05)	(0.04)
	Free cash flow	—	—	—	(0.27)	(0.47)	(0.43)	(0.85)	(0.07)	0.08	0.26
	Book value	—	—	—	0.00	(0.87)	2.96	1.13	0.45	0.42	0.48
	Shares, m	—	—	—	32	34	102	148	132	124	126
Valuation, ×
Valuation, ×	P/E	—	—	—	0.00	0.00	0.00	28.90	0.00	0.00	0.00
	P/S	—	—	—	0.00	0.00	9.49	3.72	1.02	0.59	0.58
	P/B	—	—	—	16,325.50	130.07	8.16	8.14	6.85	3.80	2.88
	EV/Sales	—	—	—	0.00	0.00	8.84	4.19	1.58	1.15	1.02
	EV/FCF	—	—	—	0.00	(75.84)	(52.28)	(12.22)	(64.29)	41.12	9.51
Cash, $m
Cash, $m	Operating cash flow	—	—	—	2	(12)	(28)	(107)	22	16	37
	Capex	—	—	—	(10)	(4)	(16)	(19)	(32)	(7)	(5)
	Free cash flow	—	—	—	(9)	(16)	(44)	(125)	(10)	9	32
Balance, $m
Balance, $m	Working capital	—	—	—	—	28	924	712	583	409	123
	Total debt	—	—	—	—	217	734	741	738	552	364
	Net debt	—	—	—	—	207	(168)	173	215	182	132
	Shareholders’ equity	—	—	—	—	(30)	302	167	59	52	61
Returns, %
Returns, %	ROA	—	—	—	0.00	(26.19)	(52.55)	3.98	(10.36)	(3.60)	(1.61)
	ROIC	—	—	—	0.00	(6.06)	(18.58)	(4.75)	(29.78)	(18.11)	(6.74)
	ROE	—	—	—	0.00	(21.45)	(278.16)	18.84	(88.42)	(52.34)	(16.87)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
NUS Nu Skin Enterprises, Inc.	$253.6M	— (loss-making)	5.9×	−17.10% (below 0%: shrinking)	n/m	−86.06% (below 0%: shrinking)	68.20%	(18.53%)	Compare
ACU Acme United Corporation.	$237.5M	23.9×	31.0×	+16.15% (above 0%: growing)	+4.76% (above 0%: growing)	+155.61% (above 0%: growing)	42.55%	10.89%	Compare
YSG Yatsen Holding Limited Sponsored ADR	$169.0M	— (loss-making)	32.2×	+10.97% (above 0%: growing)	n/m	+14.56% (above 0%: growing)	73.88%	(11.55%)	Compare
MLKMF Waldencast PLC	$111.9M	— (loss-making)	— (loss-making)	—	n/m	−345.38% (below 0%: shrinking)	46.91%	0.00%	Compare
SKIN SkinHealth Systems Inc.	$82.0M	— (loss-making)	— (loss-making)	−7.77% (below 0%: shrinking)	n/m	−81.89% (below 0%: shrinking)	68.42%	4.95%
SLSN Solesence, Inc.	$62.8M	— (loss-making)	—	−24.69% (below 0%: shrinking)	n/m	+86.52% (above 0%: growing)	30.97%	0.79%	Compare
GROV Grove Collaborative Holdings, Inc.	$42.5M	— (loss-making)	— (loss-making)	−16.94% (below 0%: shrinking)	n/m	+101.08% (above 0%: growing)	53.56%	(2.14%)	Compare
UG United-Guardian, Inc.	$31.5M	12.7×	18.7×	+9.52% (above 0%: growing)	+14.29% (above 0%: growing)	+428.43% (above 0%: growing)	49.73%	24.26%	Compare
DSY Big Tree Cloud Holdings Limited	$27.3M	18.1×	—	—	0.00%	−267.22% (below 0%: shrinking)	—	—	Compare
Median of peers	$87.3M	18.1×	24.9×	−3.71%	+4.76%	+50.54%	49.73%	0.00%

All 32 Household & Personal Products stocks →

SkinHealth Systems Inc. (SKIN) key facts

Concern: SkinHealth Systems Inc.’s revenue for fiscal 2025 (year ended December 2025) was $300.8 million, down 10.0% from fiscal 2024.
SkinHealth Systems Inc. (SKIN) is a Household & Personal Products company in the Consumer Defensive sector, listed on Nasdaq.
As of October 16, 2026, SKIN traded at $10.56, a market capitalization of $82.0 million.
Return on equity was −16.9% and debt-to-equity 6.21.
Its Piotroski F-score is 6 out of 9 and its Altman Z-score is −0.45 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.